Guillaume Ravel, PharmD, PhD, DABT

Guillaume Ravel, PharmD, PhD, DABT has a comprehensive work experience in the pharmaceutical industry. Since January 2020, they have been serving as the Director of Preclinical Development at Amolyt Pharma. Prior to this role, from August 2016 to December 2019, they worked as a Toxicology Expert at Sanofi Pasteur. Guillaume also held the position of Senior Toxicologist at Sanofi Pasteur from January 2007 to August 2016. Before joining Sanofi Pasteur, they worked as a Study Director at MDS Pharma Services from November 2002 to January 2007.

Guillaume Ravel, PharmD, PhD, DABT, completed their education at Université Claude Bernard (Lyon I) with a PharmD and PhD degree in Toxicology, which was obtained in 2004. They have also obtained a certification as a Diplomate of the American Board of Toxicology from the American Board of Toxicology, Inc. However, the specific month and year for the certification are not provided.